Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuichi Sakate

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Scientific Reports|June 12, 2021
Drug target gene-based analyses of drug repositionability in rare and intractable diseasesRyuichi Sakate, Tomonori Kimura
Drug Discovery Today|February 1, 2022
Drug repositioning trends in rare and intractable diseasesRyuichi Sakate, Tomonori Kimura
NAR Molecular Medicine|November 19, 2025
Trends in drug development for rare and intractable diseases based on the KEGG NETWORKMao Tanabe, Makoto Hirata, Ryuichi Sakate
Gene|May 15, 2012
Evolutionary growth process of highly conserved sequences in vertebrate genomesMinaka Ishibashi, Akiko Ogura Noda, Ryuichi Sakate, et al.
RNA (New York, N.Y.)|October 25, 2022
i-tRAP (individual tRNA acylation PCR): A convenient method for selective quantification of tRNA chargingYusuke Tsukamoto, Yumi Nakamura, Makoto Hirata, et al.
Current Clinical Pharmacology|June 6, 2018
Trends of Clinical Trials for Drug Development in Rare DiseasesRyuichi Sakate, Akiko Fukagawa, Yuri Takagaki, et al.
Clinical and Experimental Nephrology|July 29, 2023
Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal recordsNaoki Nakagawa, Tomonori Kimura, Ryuichi Sakate, et al.
FEBS Letters|April 20, 2023
GCN2 kinase-mediated upregulation of ubiquitin C maintains intracellular glutamine level and tRNA<sup>Gln</sup> (CUG) charging under amino acid starvationYusuke Tsukamoto, Yumi Nakamura, Makoto Hirata, et al.
Clinical and Experimental Nephrology|April 19, 2026
Characteristics of newly diagnosed systemic lupus erythematosus patients with or without kidney involvement: analysis of the National Database of Designated Intractable Diseases of JapanHidekazu Ikeuchi, Tomonori Kimura, Ryuichi Sakate, et al.
Clinical and Experimental Nephrology|March 17, 2023
Profiling of kidney involvement in systemic lupus erythematosus by deep learning using the National Database of Designated Incurable Diseases of JapanTomonori Kimura, Hidekazu Ikeuchi, Mitsuaki Yoshino, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Scientific Reports|June 12, 2021
Drug target gene-based analyses of drug repositionability in rare and intractable diseasesRyuichi Sakate, Tomonori Kimura
Drug Discovery Today|February 1, 2022
Drug repositioning trends in rare and intractable diseasesRyuichi Sakate, Tomonori Kimura
NAR Molecular Medicine|November 19, 2025
Trends in drug development for rare and intractable diseases based on the KEGG NETWORKMao Tanabe, Makoto Hirata, Ryuichi Sakate
Gene|May 15, 2012
Evolutionary growth process of highly conserved sequences in vertebrate genomesMinaka Ishibashi, Akiko Ogura Noda, Ryuichi Sakate, et al.
RNA (New York, N.Y.)|October 25, 2022
i-tRAP (individual tRNA acylation PCR): A convenient method for selective quantification of tRNA chargingYusuke Tsukamoto, Yumi Nakamura, Makoto Hirata, et al.
Current Clinical Pharmacology|June 6, 2018
Trends of Clinical Trials for Drug Development in Rare DiseasesRyuichi Sakate, Akiko Fukagawa, Yuri Takagaki, et al.
Clinical and Experimental Nephrology|July 29, 2023
Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal recordsNaoki Nakagawa, Tomonori Kimura, Ryuichi Sakate, et al.
FEBS Letters|April 20, 2023
GCN2 kinase-mediated upregulation of ubiquitin C maintains intracellular glutamine level and tRNA<sup>Gln</sup> (CUG) charging under amino acid starvationYusuke Tsukamoto, Yumi Nakamura, Makoto Hirata, et al.
Clinical and Experimental Nephrology|April 19, 2026
Characteristics of newly diagnosed systemic lupus erythematosus patients with or without kidney involvement: analysis of the National Database of Designated Intractable Diseases of JapanHidekazu Ikeuchi, Tomonori Kimura, Ryuichi Sakate, et al.
Clinical and Experimental Nephrology|March 17, 2023
Profiling of kidney involvement in systemic lupus erythematosus by deep learning using the National Database of Designated Incurable Diseases of JapanTomonori Kimura, Hidekazu Ikeuchi, Mitsuaki Yoshino, et al.
Pageof 3